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Abstract 
 
Aims−Duchenne muscular dystrophy (DMD), a degenerative pathology of skeletal muscle, also 
induces cardiac failure and arrhythmias due to a mutation leading to the lack of the protein 
dystrophin. In cardiac cells, the subsarcolemmal localization of dystrophin is thought to protect the 
membrane from mechanical stress. The absence of dystrophin results in an elevated stress-induced 
Ca
2+ 
influx due to the inadequate functioning of several proteins, such as stretch-activated channels 
(SACs). Our aim was to investigate whether transient receptor potential vanilloid channels type 2 
(TRPV2) form subunits of the dysregulated SACs in cardiac dystrophy. 
 
Methods and Results−We defined the role of TRPV2 channels in the abnormal Ca2+ influx of 
cardiomyocytes isolated from dystrophic mdx mice, an established animal model for DMD. In 
dystrophic cells, Western blotting showed that TRPV2 was twofold overexpressed. While normally 
localized intracellularly, in myocytes from mdx mice TRPV2 channels were translocated to the 
sarcolemma and were prominent along the T- tubules, as indicated by immunocytochemistry. 
Membrane localization was confirmed by biotinylation assays. Furthermore, in mdx myocytes 
pharmacological modulators suggested an abnormal activity of TRPV2, which has a unique 
pharmacological profile among TRP channels. Confocal imaging showed that these compounds 
protected the cells from stress- induced abnormal Ca
2+ 
signals. The involvement of TRPV2 in these 
signals was confirmed by specific pore-blocking antibodies and by siRNA ablation of the TRPV2 
gene. 
 
Conclusions−Together, these results establish the involvement of TRPV2 in a stretch-activated 
calcium influx pathway in dystrophic cardiomyopathy, contributing to the defective cellular Ca
2+ 
handling in this disease.  
 
Keywords: mdx cardiomyocytes, calcium, SACs, TRPV2 channels, dystrophy
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Introduction 
 
Duchenne muscular dystrophy (DMD) is a X-linked degenerative pathology of skeletal 
muscle, affecting 1 in 3‟500 male births. Initially, this progressive disease causes muscle 
weakness and an impaired mobility requiring a wheelchair by 8-12 years of age. Subsequently, 
DMD is responsible for the slow development of respiratory failure. Medical advances, such as 
therapies for respiration support, have prolonged the life expectancy of patients to around 25 
years. However, cardiac muscle manifestations are present in essentially all patients by 20 years 
of age. The heart develops a dilated cardiomyopathy (DCM) resulting in cardiac failure and 
arrhythmias causing the death of ~20% of all patients.
1
  
DMD results from a mutation in the Dys gene located on the X chromosome. This genetic 
alteration is responsible for the absence of the protein dystrophin.
2
 Dystrophin is a rod-shaped 
protein expressed in muscle fibers. In cardiomyocytes, its subsarcolemmal and sarcomeric 
localization along the T-tubule network is essential to maintain the membrane architecture.
3
 
Dystrophin is associated with the dystrophin-glycoprotein complex (DGC) which is composed 
of several transmembrane proteins such as α-, β- dystroglycans; α-, β-, γ-,δ- sarcoglycans and 
sarcospans. These proteins provide a mechanical link between the extracellular matrix, via 
laminin binding, and the cytoskeleton, via F-actin binding.
4
 This molecular bridge is thought to 
preserve the membrane integrity during mechanical stress.
5
 The DGC is also involved in the 
maintenance of the normal cellular Ca
2+
 gradient via the regulation of several proteins.
6,7
 In 
general, the absence of dystrophin increases the membrane fragility, either directly or indirectly. 
This can be determined with a variety of experimental techniques and is often detected as an 
elevated stress-induced Ca
2+
 influx from the extracellular space.
8
 Generally, two distinct Ca
2+
 
influx pathways have been considered, both in skeletal muscle fibers and in cardiomyocytes. 1) 
Localized microruptures of the sarcolemma result in abnormal stress-induced entry of Ca2+ (and 
other ions) into the cells.
9,10
 2) As mentioned above, loss of dystrophin seems to be responsible 
for the dysregulation of a number of proteins, such as stretch-activated channels (SACs), which 
constitute an alternative pathway for Ca2+ entry into myocytes.
11,12
 SACs are nonselective cation 
channels with an increased activity triggered by mechanical stress.
13,14
  
At present, the molecular identity of SACs is not known, and most likely there are several 
types of SACs expressed in skeletal and cardiac muscle. Some of the SACs are thought to 
contain ion channel proteins from the large family of transient receptor potential (TRP) 
channels, such as TRPV2 or TRPC1. Since preventing abnormal Ca
2+  
influx via SACs could be 
a strategy to ameliorate dystrophy (and other diseases), there is considerable interest in the 
molecular underpinnings and functioning of these channels 
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In addition to enlarged Ca
2+
 sarcolemmal influx, it has been observed that in dystrophic 
cardiomyocytes the entire Ca
2+
 signaling system, in particular the Ca
2+
-induced Ca
2+  
release 
mechanism, shows an abnormal susceptibility to generate exaggerated Ca
2+ 
signals, such as Ca
2+ 
sparks and Ca
2+  
waves.
15
 This seems to result, at least partly, from post-translational 
modifications of the SR Ca
2+ 
release channels (a.k.a. ryanodine receptors, RyRs). As a 
consequence of all these Ca
2+ 
signaling disturbances, the resting cytosolic concentration was 
found to be slightly elevated in dystrophic cardiomyocytes.
13
 
In the present study we examined whether the transient receptor potential vanilloid type 2 
channels (TRPV2) form part of a stretch-activated channel responsible for the abnormal Ca2+ 
influx in dystrophic ventricular cardiomyocytes from mdx mice, an established animal model for 
DMD. The TRPV2 overexpression and specific re-localization to the sarcolemma and along the 
T-tubule network, highlighted by Western blot analysis and immunocytochemistry, show a 
mobilization of this protein in dystrophic cardiomyocytes. The combination of relatively 
unspecific pharmacological interventions with specific functional experiments involving pore-
blocking antibodies and siRNA mediated ablation of the protein indicate an abnormal TRPV2 
activity in dystrophic cardiomyocytes. Together these results suggest the involvement of TRPV2 
as a stretch-activated Ca2+ influx pathway in dystrophic cardiomyocytes, presumably 
contributing to the defective cellular Ca2+ handling in these cells. 
 
 
Methods 
 
Cell isolation 
 
All animal procedures conformed to the Guide for the Care and Use of Laboratory 
Animals published by the US National Institutes of Health and National Research Council of the 
National Academy of Sciences (NIH Publication No. 85-23, revised 2011), to the Swiss Animal 
Protection Law (TSchG), and were carried out with permission by local Swiss authorities 
(permit BE126/12). C57BL/10 mice (4 months old), in the following referred to as wild-type 
(WT), and C57BL/10ScScn-mdx mice of identical age were provided by Profs. M. Rüegg 
(University Basel, Switzerland) and U. Rüegg (University Geneva, Switzerland) or purchased 
from Jackson Laboratory. Animals were euthanized by cervical dislocation, followed by rapid 
removal and enzymatic dissociation of the cardiac tissue as previously described.
16
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Immunocytochemistry 
 
Cardiomyocytes were fixed with 4 % paraformaldehyde in PBS for 1 h, permeabilized 
with 0.5 % Triton X-100 in PBS for 1 h at room temperature. A blocking solution of 4 %, bovine 
serum albumin (BSA) was applied for 1 h. Cells were incubated overnight at 4 °C in a wet 
chamber with an anti-TRPV2 antibody against an extracellular epitope (1/100; Alomone ACC-
039) and an anti-NCX antibody (1/100; Thermo Scientific MA3-926) diluted in PBS 4 %, BSA 
and 0.5 % Triton X-100. After washing out in PBS, cells were incubated for 2 h in PBS 4 % 
BSA and 0.5 % Triton X-100 with secondary antibodies (Alexa Fluor 488-conjugated goat anti-
rabbit IgG and Alexa Fluor 568-conjugated donkey anti-mouse IgG; 1/100).  
 
Experimental solutions 
 
The isotonic superfusion solution contained (in mM): 140 NaCl, 5.4 KCl, 1.8 CaCl2, 1.1 
MgCl2, 5 HEPES, and 10 glucose. The osmolarity was 310 mOsm, and pH 7.3. The hypotonic 
solution contained (in mM): 70 NaCl, 5.4 KCl, 1.8 CaCl2, 1.1 MgCl2, 5 HEPES, and 10 glucose, 
and had an osmolarity of 170 mOsm. SKF96365, tranilast, ruthenium red, ryanodine and 
thapsigargin were added for at least 30 min before the experiment. The phosphate buffer solution 
(PBS) contained (in mM): 130 NaCl; 2.07 KCl; 1.5 Na2HPO4; 8 KH2PO4; pH was adjusted to 
7.4 with NaOH. 
Most chemicals were obtained from Sigma. Collagenase (type II) was purchased from 
Worthington, Di-8ANEPPS and fluo-3-AM from Biotium, tranilast from Cayman, thapsigargin 
and ryanodine from Alomone, 2-aminoethyl diphenylborinate (2-APB) and ruthenium red (RuR) 
from Fluka, TRPV2 and TRPC1 antibodies from Alomone (ACC-039 and ACC-032 for TRPV2 
and ACC-118 for TRPC1). All experiments were performed at room temperature (20ºC). 
 
Confocal microscopy 
 
Examination of immunolabelled samples and Ca
2+
 imaging were performed on an inverted 
laser-scanning confocal microscope (Olympus FV-1000) with a x60 water immersion objective 
(NA, 1.2). Cells were loaded with fluo-3-AM (5 μM) for 30 min and excited at 473 nm to record 
the fluorescence between 490 and 590 nm. Amplitude (F/F0) and time-course of Ca
2+ 
transients 
were computed using ImageJ and Igor Pro software. 
To label T-tubules, ventricular myocytes were incubated with 10 μM di-8-ANEPPS for 30 
min.
12
 After staining, the images of living cells were acquired with the confocal system. 
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Western Blot 
 
Proteins were extracted from isolated ventricular cardiomyocytes using NP40 cell lysis 
buffer (Invitrogen) supplemented with a protease inhibitor cocktail. Protein extracts were dosed 
using BCA protein assay kit (Thermo scientific) at 562 nm and then divided into samples and 
denatured by incubation in Laemmli buffer (Sigma) for 10 min at 95ºC. Subsequently, samples 
were subjected to SDS-PAGE and Western blot analysis. The blots were incubated with anti-
TRPV2 against an extracellular epitope (1/200; Alomone ACC-039) and anti-actin (1/1000) 
antibodies overnight at 4ºC and then with horseradish peroxidase-conjugated secondary anti-
rabbit and anti-mouse (1/10000, Jackson) antibodies for 1 h at room temperature. Finally, the 
blots were developed with enhanced chemiluminescent (ECL) substrates for detection of HRP 
enzymatic activity (Thermo scientific). The apparent molecular weights were estimated 
according to the position of prestained protein markers (Precision plus protein standards; Bio-
Rad). 
 
Biotinylation 
 
Isolated cardiomyocytes were incubated with biotinylation reagent (Sulfo-NHS-LC-Biotin, 
APExBIO, 0.5 mg/ml in PBS) at 37ºC for 2 h. The biotin reagent was removed and cells were 
washed twice in cold PBS with 100 mM glycine and twice in cold PBS alone. Then, lysates were 
prepared and dosed as described above. 100 μg of each samples were incubated with 100 μl of 
streptavidin agarose resin (Thermo Scientific) for 16 hours at 4ºC to capture biotinylated 
proteins. The beads were pelleted and washed in lysis buffer. Captured proteins were eluted at 
60ºC for 30 min with Laemmli 2X sample buffer containing 40 mg/mL of dithiothreitol. Then 
they were analyzed by Western blot as described above with primary antibodies: anti-TRPV2 
against an extracellular epitope (Alomone ACC-039, 1/100), anti-GAPDH (positive control, 
Fitzgerald, 1/3000), anti-P44/P42 MAPK (negative control, Cell Signaling, 1/2000). 
 
Cardiomyocyte culture and transfection 
 
Isolated cardiomyocytes were cultured in Dulbecco‟s modified Eagle‟s medium (DMEM) 
supplemented with insulin (10 mg/mL), HEPES (10 mM), NaHCO3 (4 mM), blebbistatin (25 
μM), cytochalasin D (0.5 μM). TRPV2 siRNA and non-targeting siRNA were obtained from 
Origene. Transfection of siRNA was performed using GeneSilencer (Genlantis) for 4 h. 
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Subsequently, this medium was replaced by solution without transfection reagent for 20 h. 
Lysates were prepared and dosed as described above. 
 
Real-time Polymerase Chain Reaction 
 
 Total RNA from siRNA against TRPV2 and scrambled siRNA dystrophic cardiomyocytes 
were extracted using RNA purification kit (NucleoSpin RNA, Macherey-Nagel). 
Mm_Trpv2_1_SG, Mm_Actb_1_SG were used as specific mouse RT-PCR primers (Qiagen). 
The ACTB housekeeping gene (against β-actin) and TRPV2 gene were amplified in parallel. 
Real-time RT-PCR was performed using 9 ng/μl of RNA (KAPA SYBR FAST One-Step 
Universal Kit) and 200 nM of each primer in a total reaction volume of 15 μl. Data were 
recorded on an Eco Real-Time PCR system (Illumina Labgene Scientific SA) and cycle 
threshold (Ct) values for each reaction were determined using analytical software from the same 
manufacturer. Each cDNA was amplified in duplicate, and Ct values were averaged for each 
duplicate. The average Ct value for ACTB was subtracted from the average Ct value for the gene 
of interest. As amplification efficiencies of TRPV2 genes and ACTB were comparable, the 
relation 2
-ΔCt
 gave the amount of mRNA, normalized by ACTB. 
 
Statistical analysis 
 
All results are expressed as mean ± SEM of n observations. Sets of data were compared 
using Student‟s t test, and significance is denoted as *P<0.05, **P<0.01. N refers to number of 
animals, n to number of cells. 
 
Results 
 
Osmotic stress induces abnormal Ca
2+
 signals in dystrophic cardiomyocytes  
 
As reported before, dystrophic muscle cells exhibit an abnormal membrane fragility and 
increased stretch sensitivity.
5,17
 We applied mild osmotic shocks to WT and dystrophic 
cardiomyocytes mimicking features of mechanical membrane stress during contractions (cell 
swelling by 15.8% in both, WT and mdx myocytes).
15
 After 30 minutes loading with the 
fluorescent Ca
2+
 indicator fluo-3-AM, myocytes were briefly superfused with a mildly hypotonic 
solution (40 s). The fluorescence was recorded to measure Ca
2+
 signals before, during and after 
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the osmotic stress, visible as a transient decrease of fluorescence due to dye dilution (Figure 1A 
and 1B). As described in previous studies,
15
 cardiomyocytes from mdx mice displayed an 
increased fluorescence starting after a mild osmotic stress (Figure 1B). For quantitative analysis, 
we averaged the normalized fluorescence during a 40 s time window after the osmotic stress 
(Figure 1C left). While in WT cells the fluo-3 signal returned to baseline after the stress (F/F0: 
0.98 ± 0.02, n=10), the Ca
2+
-related
 
fluorescence observed in mdx cardiomyocytes was 1.4-fold 
larger (F/F0: 1.41 ± 0.09, n=13). Besides an abnormally large transsarcolemmal Ca
2+
 influx, a 
different extent of Ca
2+
 loading of the sarcoplasmic reticulum (SR) and/or an elevated sensitivity 
of the SR Ca2+ release mechanism could explain these increased Ca2+ signals, similar to other 
pathologies with altered SR function.
16,18
 However, applying rapid puffs of caffeine containing 
solutions to estimate the Ca
2+
 SR content before and after the osmotic shock did not reveal a 
difference between dystrophic and WT cells (Figure 1C right). But the mdx cells lost 
significantly more Ca2+ than the WT myocytes, as one would expect because of their exaggerated 
Ca
2+
 signals. As it has been reported before, the excessive cytosolic Ca
2+
 signals in mdx 
cardiomyocytes observed here are triggered, at least partly, by Ca2+ influx via several pathways 
such as local microruptures in the sarcolemma and the abnormal activation of stretch-activated 
channels (SACs).
9,12,19
 The molecular identity of SACs is not yet established, but for quite some 
time TRP channels have been suspected to play a role.
19
 Recently, transient receptor potential 
vanilloid type 2 (TRPV2) channels have been proposed to be part of these SACs in dystrophic 
skeletal muscle fibers.
17,20
 Therefore, we next carried out experiments to define the role of 
TRPV2 channels in the abnormal stress induced Ca2+ signals in dystrophic cardiomyocytes. 
 
Sarcolemmal TRPV2 localization and overexpression in mdx cardiomyocytes 
 
In cultured dystrophic skeletal muscle myotubes, TRPV2 channels were found to be 
localized to the sarcolemma, where they mediated abnormal Ca
2+
 influx from the extracellular 
space.
7,17
 In physiological conditions, TRPV2 channels are mainly localized to intracellular 
membrane structures, but are known to translocate to the plasma membrane upon specific 
stimulation, such as by insulin growth factor-1 (IGF-1). Once activated, they participate in the 
function and structure of cardiomyocytes.
21,22
 Therefore, we compared the TRPV2 expression 
and its subcellular distribution in freshly isolated WT and mdx cardiomyocytes (Figure 2). 
Comparative TRPV2 immunocytochemistry in WT cardiomyocytes showed only a staining 
within the cell (Figure 2A left above). In contrast, in mdx cells TRPV2 immunofluorescence 
displayed a strong localization at the sarcolemma and along the T-tubular network (Figure 2A 
left below). This specific localization was confirmed by a double staining against the Na+-Ca2+ 
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exchanger (NCX) known to be expressed in the plasma membrane (Figure 2A middle and left).
23
 
Western blot analysis indicated a 2-fold TRPV2 overexpression in dystrophic myocytes (Figure 
2B). The specific membrane bound fraction of TRPV2 was determined using a biotinylation 
assay, and normalized to GAPDH. The amount of TRPV2 at the plasma membrane was 
increased 1.6-fold compared to WT cells (Figure 2C). 
 
Functional characterization of sarcolemmal TRPV2 channels 
 
To assess the functional consequences of the membrane specific TRPV2 overexpression in 
mdx cardiomyocytes, we initially used pharmacological tools. TRP channel pharmacology is 
notoriously unspecific, but the TRPV2 channels have a peculiar pharmacological profile that sets 
them apart from many other TRP channels. Contrary to most TRP channels, they are not blocked 
by 2-APB, but become activated (albeit at a high 2-APB concentration of 500 µM). They are 
also activated by the organic anion transporter inhibitor probenecid (Pro, 1 mM). Ruthenium red 
(RuR, 40 µM) is an unspecific and tranilast (Tran, 1 mM) a somewhat more specific inhibitor of 
TRPV2 channel activity.
24-26
 In order to experimentally examine Ca
2+ 
influx without interference 
from SR Ca
2+
 release, mdx myocytes were preincubated with thapsigargin (Tg, 1 µM) and 
ryanodine (Rya, 10 µM) (Figure 3A and 3B). Subsequently, and prior to the actual experiment, 
several stimulations with caffeine (Caff, 10 mM) were applied to completely empty the SR. 
Both, 2-APB and probenecid perfusions induced a Ca
2+
 influx upon their application (F/F0 of 
1.39 ± 0.05 and 1.78 ± 0.1, respectively) (Figure 3A and 3B). This Ca2+ influx was substantially 
reduced in the presence of the TRPV2 inhibitors (F/F0 of 1.07 ± 0.01 for RuR and 1.28 ± 0.05 in 
the presence of Tran). Taken together, these findings suggest that in isolated cardiomyocytes 
TRPV2 channels indeed mediate Ca
2+
 influx that can be reduced by TRPV2 inhibitors. With its 
localization in the sarcolemma of dystrophic myocytes and its known activation by hypotonicity 
and stretch-induced mechanical stimulation,
7,27
 a participation of TRPV2 in the excessive 
cytosolic Ca
2+
 signals could be expected.  
 
Osmotic stress activates TRPV2 channels 
 
To determine whether TRPV2 channels form part of SACs in dystrophic cardiac cells, mdx 
myocytes were exposed to stress in the presence of the TRPV2 inhibitor SKF96365 (Figure 3C, 
left). Data obtained in WT and mdx myocytes is replotted from Figure 1, for easier comparison. 
Figure 3C indicates that after the stress the Ca
2+
-related
 
fluorescence was 1.6-fold smaller in the 
presence of 30 µM SKF96365 (F/F0SKF: 0.93 ± 0.02 compared to untreated mdx cells, 1.41 ± 
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0.09). In additional experiments we applied the two TRPV2 inhibitors tranilast and RuR during 
the osmotic stress (Figure 3D). The Ca
2+
 signal was 1.5-fold smaller in the presence of tranilast, 
and 1.6-fold in RuR (F/F0Tran: 0.90 ± 0.01 and F/F0RuR: 0.93 ± 0.01 compared to untreated mdx 
cells, 1.41 ± 0.09). These findings are consistent with an involvement of TRPV2 channels. 
However, at present the TRPV2 pharmacology is not at all specific, as mentioned above.  
To allow more specific conclusions regarding the role of TRPV2 channels and their 
identification as subunits of SACs we used a two-pronged approach: 1) block of the channel 
pore with antibodies and 2) ablation of TRPV2 with specific siRNA. First, to achieve specific 
inhibition of TRPV2 channels, mdx cardiomyocytes were incubated during 24 h with TRPV2 
antibodies raised against an extracellular epitope, thereby blocking the pore to prevent cation 
influx (Figure 4A).
28
 Cardiomyocytes kept in short term culture undergo substantial 
dedifferentiation, even after 24 h. The ends of cardiomyocytes round up and, most important for 
Ca2+ signaling, the T-tubular organisation decreases. To slow down this process we added a low 
concentration of cytochalasin D (0.5 µM) that protects cardiomyocytes from the detubulation.
29
 
Compared to untreated mdx myocytes, the Ca
2+
-related
 
fluorescence response was 1.4-fold 
smaller in cells treated with this antibody (F/F0: 0.88 ± 0.03; Figure 4B). As negative control 
experiments, we incubated cells with antibodies against an intracellular epitope of TRPV2 and 
against TRPC1 (extracellular epitope). These antibodies did not protect the treated mdx cells 
from increased Ca
2+
 signals (F/F0: 1.23 ± 0.09, mdx cells; 1.25 ± 0.07, anti-TRPC1; 1.09 ± 0.09, 
anti-TRPV2 intracellular epitope). The SR Ca2+ content was not different between the various 
treatment groups excluding a possible modification of the cells caused by the short-term cell 
culture. 
Another strategy to specifically remove the function of a particular protein is to interfere 
with its expression using siRNA (Figure 5). To this end, mdx cardiomyocytes were incubated 4 
h with siRNA directed against TRPV2 and maintained in culture during 24 h.
30
 Transfected mdx 
cardiomyocytes were exposed to osmotic stress (Figure 5A). Ca
2+
-related
 
fluorescence was 1.3-
fold smaller in cells loaded with TRPV2 siRNA (F/F0: 0.94 ± 0.02) compared to the negative 
control (F/F0: 1.27 ± 0.09, Figure 5B). No difference was observed between mdx cells 
transfected with scrambled siRNA (negative control) and mdx cardiomyocytes without 
transfection and kept in culture during 24 h. Therefore the transfection by itself did not interfere 
with the Ca
2+
 signaling response after an osmotic challenge. Ca
2+
-related
 
fluorescence from WT 
cardiomyocytes (F/F0: 0.98 ± 0.02) was similar to siRNA treated mdx cells (F/F0: 0.94 ± 0.02). 
Among several necessary control experiments, we verified successful transfection of siRNA into 
cardiac myocytes. Figure 5C shows cardiomyocytes which were incubated with fluorescently 
labeled siRNA, to verify siRNA transfection. In addition, siRNA transfection and TRPV2 
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silencing were validated by Western blot analysis and by quantitative RT-PCR  (Figure 5D). In 
siRNA transfected cells, TRPV2 expression was decreased by 60% compared to the negative 
control (using scrambled siRNA). Figure 5E also highlights the integrity of the T-tubular 
network, as recorded with the fluorescent membrane dye di-8-ANEPPS. Taken together, these 
data provide strong evidence that siRNA mediated knockdown of TRPV2 normalized the stress-
induced Ca
2+
 handling in dystrophic cardiomyocytes.  
 
Discussion 
 
Dystrophin-deficient cardiomyocytes have an abnormally high membrane fragility making 
them sensitive to mechanical stress.
9
 This loss of membrane integrity leads to an increased 
permeability which allows an abnormal stress-induced influx of extracellular Ca
2+
, presumably 
via SACs and membrane microruptures.  
 
The two-hit hypothesis of dystrophic cardiomyopathy 
 
Even though the lack of functional dystrophin protein has been identified as the cause for 
many forms of this disease, the mechanism(s) linking the absence of this cytoskeletal protein 
with the observed cellular damage remains poorly understood. Several versions of a “two-hit 
hypothesis” have been proposed as pathomechanisms of muscular dystrophies and dystrophic 
cardiomyopathies.
31
 These hypotheses postulate a combined effect of abnormal Ca
2+
 signals, 
both from sarcolemmal influx and SR leak, and oxidative stress. In normal muscle, the neuronal 
nitric oxide synthase (nNOS) is a member of the dystrophin-glycoprotein complex and localized 
at the sarcolemma. NO can protect cells from stronger oxidative damage by playing an 
antioxidant role, and by inhibiting NADPH oxidases, the major sources of reactive oxygen 
species (ROS).
32
 In dystrophic myocytes, nNOS is down-regulated contributing to an enhanced 
generation of ROS.
33
 In these cells the abnormal Ca
2+
 influx and release further stimulate ROS 
production by mitochondria and NADPH oxidases, particularly after mechanical stress.
15,34
 As a 
consequence, these ROS may lead to further Ca
2+
 influx by increasing the membrane 
permeability via lipid peroxidation and to additional SR release by oxidation of several 
proteins.
35
 Thus, in cardiac muscle, the Ca
2+
 signaling pathology defined by the two-hit 
hypothesis has two components: 1) hypersensitive Ca
2+
-induced Ca
2+
 release from the SR (e.g. 
as sparks or invisible leak), presumably as a result of post-translational modifications of the 
RyRs (e.g. oxidation, phosphorylation, or hypernitrosylation).
16,36-39
 2) abnormally high Ca
2+
 
influx across the fragile sarcolemma, particularly after mechanical stress.
5,10,12,40
 The relative 
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importance of these two mechanisms seems to change during the progression of the disease, with 
the SR leak becoming more and more prominent.
36
 Overall, the two-hit mechanism creates an 
endless loop of abnormal Ca
2+
 entry and oxidative damage that may culminate in activation of 
Ca
2+
 dependent proteases and apoptotic or necrotic cell death. In principle, both mechanisms 
could offer multiple possibilities and targets for future pharmacological treatments.  
 
Ca
2+
 influx via stretch-activated membrane channels 
 
In the present study we focused on one of the putative pathomechanism involved in 
abnormal Ca
2+
 influx: stretch-activated membrane channels (SACs). The molecular identity of 
SACs involved in dystrophy is presently unknown. However, previous studies have proposed 
several candidates as potential SAC subunits in mdx cardiomyocytes to explain the elevated Ca
2+
 
entry during mechanical stress, such as transient receptor potential canonical channel 1 (TRPC1) 
and 6 (TRPC6).
19,41
 Others reported TRPV2 channels to play an important role in dystrophic 
skeletal muscle fibers.
17,20
 Interestingly, overexpression of TRPC3 channels resulted in a 
dystrophy-like phenotype.
42
 Most of these TRP channels form cation channels that are 
permeable to monovalent and divalent ions, thus carrying entry of both, Na
+
 and Ca
2+
.
43
  
 
Identification of TRP channels contributing to SACs 
 
Unfortunately, the pharmacological tools available to identify particular TRP channels as 
components of SACs are very unspecific. Most of those compounds affect several or many TRP 
channels in the same range of concentrations. Therefore, we applied a multipronged approach as 
the strategy to define the role of TRP channels in the abnormal Ca
2+ signals we observed. Using 
several available but unspecific pharmacological tools we established a pharmacological profile 
of the abnormal Ca
2+ 
signals, as detailed below. This pharmacological profile turned out to be 
quite unique and suggested that TRPV2 channels might be involved. As a second approach we 
examined the TRPV2 expression and cellular distribution in normal and dystrophin-deficient 
cardiomyocytes. These results indicated that TRPV2 channel might indeed play a role in the 
disease phenotype. Finally, we used more specific tools to pin-point TRPV2 as a component of 
SACs in dystrophic myocytes. This included the use of blocking antibodies raised against an 
extracellular epitope of the channels, and the application of siRNA technology to ablate the 
TRPV2 protein. 
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TRPV2 protein is overexpressed in dystrophic cardiomyocytes 
 
Histologically, TRPV2 proteins have been identified in various tissues and organs such as 
brain, lungs, skeletal and cardiac muscle.
44
 Their function is not yet well elucidated, but previous 
studies highlighted their involvement in sensation of excessive heat, osmosensory mechanisms, 
insulin exocytosis and cardiovascular functions.
7,27,45,46
 Under physiological conditions, 
immunoelectron microscopy studies revealed a TRPV2 localization in intracellular membrane 
compartments, specifically in the endoplasmic reticulum. Nevertheless, upon specific 
stimulation, TRPV2 proteins are translocated to the sarcolemma to mediate an extracellular Ca
2+
 
influx.
47
 It has been proposed that the translocation of TRPV2 could resemble that of glucose 
transporter 4 (GLUT4). GLUT4 is an insulin-regulated glucose transporter translocated from an 
intracellular storage to the plasma membrane upon insulin stimulation in adipocytes and in 
skeletal muscle fibers. Upon insulin growth factor-1 (IGF-1) stimulation, TRPV2 channels are 
targeted to the sarcolemma via the phosphatidylinositol 3-kinase (PI3K) pathways.
46,48
 Recently, 
new insight about this cation channels has been obtained in several pathological conditions. In 
dystrophic skeletal muscle fibers and myotubes in culture, TRPV2 channels were observed to be 
translocated from the intracellular space to the sarcolemma.
17,20,49,50
 In agreement with these 
observations, in our study, mdx cardiomyocytes displayed a strong TRPV2 localization at the 
sarcolemma and along the T-tubular network, when compared to WT cells. Moreover, we found 
that this abnormal translocation is accompanied by a TRPV2 overexpression, particularly at the 
sarcolemma, as suggested by biotinylation assays. Together, the elevated expression and 
translocation of TRPV2 channels in dystrophic cardiomyocytes are clearly consistent with their 
possible role in SACs and, further, suggest a stronger activity of TRPV2 in these cells.  
 
TRPV2 as potential components of SACs is supported by unspecific TRP 
channel pharmacology 
 
To assess the TRPV2 function at the plasma membrane of dystrophic myocytes, a 
pharmacological approach was used. As mentioned above, a known problem in the field of TRP 
channel research is the lack of highly specific pharmacological tools.
51
 Furthermore, the 
efficiency of many compounds depends on the cell type and even the species.
47
 In many cases, 
several unspecific compounds are used experimentally to block various TRP channels, such as 
ruthenium red, 2-APB, and SKF96365. For few channels some specific agonists are available, 
such as capsaicin for TRPV1 channels. Another promising strategy is to apply a compound that 
activates some TRP channels but blocks others. 2-APB, which is a blocker of many TRP 
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channels, was the first activator identified for some TRPV channels, including TRPV2, in 
HEK293 cells.
47
 Indeed, in our experiments with cardiomyocytes pretreated with thapsigargin 
and ryanodine (to eliminate SR function), the application of 2-APB elicited Ca
2+ influx from the 
extracellular space, that could be inhibited with ruthenium red. Consistent with a role of TRPV2 
in Ca
2+ 
influx, the blocker SKF96365 also suppressed the stress induced Ca
2+
 signals.
26
 There 
are two pharmacological TRPV2 modulators, probenecid and tranilast (activator and inhibitor, 
respectively) that have been reported to exhibit somewhat better specificity for TRPV2 channels. 
Probenecid was initially synthesized to reduce the renal excretion of antibiotics, particularly 
penicillin, and recently it has been identified as an agonist of TRPV2.
52,53
 Tranilast is clinically 
used as an antiallergic drug and experimentally as a TRPV2 antagonist.
46
 Both compounds 
changed Ca
2+
 influx in dystrophic myocytes with eliminated SR function in a way that was 
perfectly consistent with TRPV2 underlying this kind of influx. In summary, the analysis of the 
pharmacological profile revealed by our experiments allowed us to consider a pathological 
TRPV2 function in mdx cardiomyocytes.  
 
Specific inhibition of TRPV2 protects dystrophic myocytes from abnormal 
Ca
2+ 
signals 
 
To specifically probe whether TRPV2 channels are responsible for the Ca
2+
 increase after 
an osmotic shock in dystrophic myocytes, we applied an antibody raised against an extracellular 
epitope of the channel. If the channel pores are indeed blocked by these antibodies, this strategy 
suppresses the TRPV2 protein function and Ca
2+
 can no longer enter the cytoplasm. However, 
the specificity of blocking antibodies has been challenged in different studies and may depend 
on a variety of parameters such as the type of experiments (Western blot, 
immunocytochemistry), species (rat, mouse), type of antibodies (polyclonal, monoclonal). 
Therefore, we carried out several control experiments using other antibodies during the osmotic 
stress. As negative control experiments, we used antibodies raised against an intracellular 
epitope of the TRPV2 channel and against an extracellular epitope of TRPC1. In these 
experiments, we did not observe any inhibition of the TRPV2 function since the Ca
2+
-related 
fluorescence in mdx cells increased in the same manner as without antibodies. Therefore, we 
concluded that incubation with a TRPV2 antibody against an extracellular epitope eliminated the 
stress-induced signals by specifically blocking TRPV2.  
Another approach to specifically interfere with the function of the channel is the use of 
small interfering RNA (siRNA) against TRPV2 mRNA. After entering the cell by transfection, 
this specific siRNA binds the TRPV2 mRNA by complementarity. This binding prevents the 
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TRPV2 mRNA translation after transcription by specific destruction of the mRNA by 
exonucleases, essentially preventing the protein synthesis. After incubation of mdx myocytes 
with siRNA, Western blot and quantitative RT-PCR experiments confirmed the decrease of the 
expression of TRPV2 protein (down to 40 % ) compared to dystrophic cells transfected with 
scrambled siRNA. Myocytes were maintained in short-term primary culture for 24 h before 
carrying out the experiments to allow for the normal degradation of pre-existing TRPV2 protein. 
The results showed that the Ca
2+
-related fluorescence after an osmotic challenge in mdx 
myocytes transfected with anti-TRPV2 siRNA was comparable to WT cells, while mdx 
myocytes transfected with scrambled siRNA behaved like untransfected dystrophic cells.  
 
Conclusion 
 
Taken together, our observations indicate a major role of TRPV2 channels in the cardiac 
dystrophic Ca
2+ 
signaling pathology and provide compelling evidence that the TRPV2 proteins 
form a subunit of stretch activated channels. 
 
TRPV2 channels and dystrophinopathies 
  
Dystrophinopathies give rise to a wide spectrum of muscle diseases. Most forms include 
cardiac muscle participation. The most severe is DMD, characterized by the absence of 
dystrophin. Becker muscular dystrophy (BMD) results in a milder phenotype since dystrophin is 
produced but only partly functional. In X-linked cardiomyopathy (XLDCM), dystrophin is 
absent only in the cardiac muscle. These three dystrophinopathies all progress into a dilated 
cardiomyopathy.
54
 As mentioned above, the two-hit hypothesis postulates a major pathological 
role for abnormal Ca
2+
 influx across the sarcolemma as one of the main pathomechanisms. Our 
study reveals that TRPV2 proteins are abnormally recruited and activated in dystrophic cardiac 
myocytes. Thus, the TRPV2 proteins, their function and translocation pathway could be relevant 
targets for future pharmacological treatments of these and related pathologies. 
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Figure legends: 
 
Figure 1 Stress-induced intracellular Ca
2+ 
signals in mdx and wild-type (WT) mouse ventricular 
cardiomyocytes. (A) Images of Ca
2+
-related fluo-3 fluorescence obtained in WT (top) and mdx 
cardiomyocytes (bottom) at the indicated times before (10 s) during (50 s) and after the osmotic 
stress (80 s and 200 s). Note the more pronounced Ca
2+ 
signals in mdx myocytes. (B) Time 
course of normalized and averaged Ca
2+
-related fluorescence, pooled from mdx (black circles) 
and WT (grey circles) cardiomyocytes undergoing the osmotic stress protocol. The lines on the 
top represent the protocol by which extracellular solutions were changed. (C) Left, mean values 
of normalized fluorescence during 40 s after the osmotic shock. Right, estimates of SR Ca
2+ 
content by 10 mM caffeine stimulation before and after the osmotic challenge. n=10-17 cells 
from N=2 mice for WT; and n=13-14 from N=2-4 for mdx. * P < 0.05, ** P < 0.01, ns: not 
significant. 
 
Figure 2 Subcellular TRPV2 localization and expression in mdx cardiomyocytes. (A) 
Immunostaining against an extracellular epitope of TRPV2 (green) and NCX (red) in WT 
(above) and mdx (below) cardiomyocytes. (B) Western blot analysis of normalized TRPV2 
channnels and β-actin expression in cardiac myocytes. Blot was cut to reduce a wide gap 
between neighboring lanes and bands. (C) Sarcolemma specific TRPV2, GAPDH (control), and 
P44/P42 MAPK (negative control) expressions (quantified by Western blot after biotinylation). 
P44/P42 MAPK and GAPDH signals were obtained by reprobing after stripping, the TRPV2 
band is contrast enhanced. Cardiomyocytes were isolated from N=4-7 mdx and WT mice. * P < 
0.05, ** P < 0.01. 
 
Figure 3 Pharmacology of transient receptor potential vanilloid type 2 (TRPV2) channels. (A) 
Left, time courses of cytosolic Ca
2+ 
in mdx cardiomyocytes during application of the TRPV2 
activator 2-APB (500 μM, at the arrow), with or without the TRPV2 inhibitor ruthenium red 
(RuR, 40 μM). Cells were pretreated with thapsigargin (Tg, 1 μM), ryanodine (Rya, 10 μM) and 
caffeine puffs (Caff, 10 mM) to suppress SR function. Right, mean values of normalized Ca2+ 
related fluorescence averaged between 90 and 100 s. (B) Left, time courses of cytosolic Ca
2+
 in 
mdx myocytes with abolished SR, then perfused (arrow) with the TRPV2 activator probenecid 
(Pro, 1 mM), with or without the TRPV2 inhibitor tranilast (Tran, 1 mM). Right, mean values of 
normalized Ca2+-related fluorescence averaged during 20 s at the end of the recording. (C) and 
(D) Left, time courses of normalized average fluorescence pooled from in mdx (black circles, C 
and D), WT (dark grey circles, C), mdx cardiomyocytes perfused with the inhibitors SKF 96365 
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(30 μM; light grey circles, C), RuR (40 μM; light grey circles, D), and Tran (1 mM; dark grey 
circles, D). The lines on the top represent the protocol by which extracellular solutions were 
changed. Time courses of WT and mdx myocytes are replotted from Figure 1 for easier 
comparison with the trace obtained from dystrophic cells in the presence of SKF 96365, RuR 
and Tran. (C) and (D) Right, mean values of normalized fluorescence during 40 s after the 
osmotic shock. n = 8-25, N=2 for each experiment. ** P < 0.01. 
 
Figure 4 Stress-induced intracellular Ca
2+ 
signals reduced by TRPV2 antibody in mdx 
ventricular cardiomyocytes. (A) Time courses of normalized Ca
2+
-related fluorescence pooled 
from mdx cardiomyocytes pretreated (grey circles) or not (black circles) with an antibody against 
an extracellular epitope of TRPV2 (Alomone ACC-39). The lines on the top represent the 
protocol by which extracellular solutions were changed. (B) Mean values of normalized 
fluorescence during 40 s following the osmotic shock in blocking antibodies against an 
extracellular epitope of TRPV2 and negative control antibodies (against an intracellular epitope 
of TRPV2 and against an extracellular epitope of TRPC1). (C) Estimates of SR Ca
2+ 
content by 
10 mM caffeine stimulation. Each experiment n=4-9 and N=2. ** P < 0.01, ns: not significant. 
 
Figure 5 SiRNA ablation of TRPV2 in mdx cardiomyocytes. (A) Time courses of normalized 
Ca2+ related fluorescence pooled from mdx myocytes transfected with siRNA directed against 
TRPV2 (grey circles) or scrambled siRNA as a negative control (black circles). Line on the top 
represents the protocol by which extracellular solutions were changed. (B) Mean values of 
normalized fluorescence during 40 s after the osmotic shock obtained from untransfected mdx 
myocytes, mdx cells transfected with scrambled siRNA, mdx cells transfected with siRNA 
against TRPV2 and WT cardiomyocytes. WT data replotted for comparison. (C) Fluorescence 
and transmission images of mdx ventricular cardiomyocytes showing successful transfection 
with fluorescently labelled siRNA. (D) Statistical analysis of reduced protein and messenger 
RNA expressions by Western blot (left and inset) and by RT-PCR (right) in mdx cardiomyocytes 
after transfection with siRNA directed against TRPV2. (E) Confocal images of T-tubular 
network with di-8ANEPPS membrane staining after transfection with scrambled siRNA and 
siRNA against TRPV2, respectively. n=7-11, N=4-8. * P < 0.05, ** P < 0.01, ns: not significant.  
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